Test Code LAB1235221 Somatostatin (Somatotropin Release-Inhibiting Factor, SRIF)
Performing Laboratory
Inter Science Institute
Specimen Required
Patient preparation:
1. Patient should be fasting 10-12 hours prior to collection.
2. Patient should not be on any medications that affect insulin secretion or intestinal motility, if possible for at least 48 hours prior to collection.
Specimen Type: Plasma
Container/Tube: EDTA tube containing GI preservative: EDTAGI
Specimen Volume: 1 mL
Collection Instructions: Collect 10 mL of blood in special tube containing G.I. Preservative (T125). Specimen should be separated immediately and send 3 mL plasma frozen as soon as possible.
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
GI Plasma | Frozen | 90 days |
Reject Due To
Hemolysis | Mild reject; Gross reject |
Lipemia | Mild reject; Gross reject |
Icterus | NA |
Other | Specimens other than Plasma collected in GI preservative (T125). Test is strict frozen |
Day(s) Performed
Performed Monday through Friday
Report avaiable within 7 to 11 days
Method Name
Direct Radioimmunoassay (RIA)
CPT Code Information
84307
Clinical Information
Somatostatin is a cyclic peptide originally isolated from sheep hypothalami and shown to inhibit the release of Growth Hormone. Somatostatin is present primarily in three main forms: a 14 amino acid peptide, a 28 amino acid peptide (“Big” Somatostatin), and a 12,000 molecular weight ProSomatostatin. This assay measures only the 14 amino acid form of Somatostatin. All three forms of Somatostatin have similar biological properties and overall potencies. Somatostatin is a physiological regulator of islet cell and gastrointestinal functions, and is a suppressor of many pituitary hormones including Growth Hormone, Prolactin, and Thyrotropin (TSH). Somatostatin levels are often elevated in diabetics, but the levels return to normal upon correction of the hormonal and metabolic deficiencies present. In many cases of APUDomas including VIPoma, Insulinoma, Glucagonoma, and Gastrinoma, elevated levels of Somatostatin are found.
Reference Values
Up to 25 pg/mL